imiquimod has been researched along with Lymph Node Metastasis in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 7 (70.00) | 29.6817 |
| 2010's | 3 (30.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bulten, J; de Hullu, JA; Fons, G; Lok, CAR; Massuger, LFAG; Oonk, MHM; Slangen, BMF; van der Linden, M; van Doorn, HC; van Dorst, EBL; van Poelgeest, MIE | 1 |
| Bourgault-Villada, I; Clerici, T; Elfatoiki, FZ; Longvert, C; Roudier-Pujol, C; Saiag, P; Vasseur, E | 1 |
| Barbosa, VH; Beutner, KR; Bhushan, R; Bichakjian, CK; Chuang, TY; Duvic, M; Foote Hood, A; Grichnik, JM; Halpern, AC; Ho, VC; Johnson, TM; Smith Begolka, W; Sober, AJ; Swetter, SM; Tsao, H | 1 |
| Pföhler, C; Reinhold, U; Tilgen, W; Ugurel, S; Wagner, A | 1 |
| Binder, B; Cerroni, L; Kerl, H; Richtig, E; Smolle, J; Wolf, IH | 1 |
| Beyeler, M; Burg, G; Dummer, R; Morcinek, J | 1 |
| Kerl, H; Kopera, D; Richtig, E; Wolf, IH | 1 |
| Bogeschdorfer, F; Gronau, S; Riechelmann, H | 1 |
| Goh, MS | 1 |
2 review(s) available for imiquimod and Lymph Node Metastasis
| Article | Year |
|---|---|
[Cutaneous neoplasms].
Topics: Adjuvants, Immunologic; Aminoquinolines; Antimetabolites, Antineoplastic; Antineoplastic Agents; Biopsy; Bowen's Disease; Carcinoma, Basal Cell; Carcinoma, Merkel Cell; Carcinoma, Squamous Cell; Clinical Trials as Topic; Combined Modality Therapy; Cryotherapy; Diagnosis, Differential; Female; Fluorouracil; Hemangiosarcoma; HIV Infections; Humans; Imiquimod; Immunotherapy; Keratosis; Lymph Node Excision; Lymphatic Metastasis; Lymphoma; Male; Melanoma; Neoplasm Recurrence, Local; Photochemotherapy; Randomized Controlled Trials as Topic; Sarcoma, Kaposi; Skin; Skin Neoplasms; Time Factors | 2003 |
[New substances in the therapy of head and neck cancer].
Topics: Administration, Oral; Aminoquinolines; Angiogenesis Inhibitors; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Bevacizumab; Carcinoma, Basal Cell; Carcinoma, Non-Small-Cell Lung; Cetuximab; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Colorectal Neoplasms; Controlled Clinical Trials as Topic; Double-Blind Method; Erlotinib Hydrochloride; Fibroblast Growth Factor 7; Gefitinib; Head and Neck Neoplasms; Humans; Imiquimod; Infusions, Intravenous; Iodine Radioisotopes; Lung Neoplasms; Lymphatic Metastasis; Lymphoma, Non-Hodgkin; Ointments; Protein Kinase Inhibitors; Quinazolines; Radioimmunotherapy; Randomized Controlled Trials as Topic; Skin Neoplasms; Time Factors; United States; United States Food and Drug Administration | 2006 |
8 other study(ies) available for imiquimod and Lymph Node Metastasis
| Article | Year |
|---|---|
Vulvar Paget disease: A national retrospective cohort study.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Disease-Free Survival; Female; Humans; Imiquimod; Kaplan-Meier Estimate; Lymphatic Metastasis; Middle Aged; Neoplasm Invasiveness; Neoplasm Recurrence, Local; Netherlands; Paget Disease, Extramammary; Retrospective Studies; Survival Rate; Vulvar Neoplasms; Vulvectomy | 2019 |
[In-transit metastasis in melanoma: Efficacy of topical imiquimod combined with carbon dioxide laser or with electrocautery].
Topics: Administration, Cutaneous; Adult; Aged; Aminoquinolines; Antineoplastic Agents; Combined Modality Therapy; Disease Progression; Electrocoagulation; Facial Neoplasms; Fatal Outcome; Humans; Imiquimod; Interferon-alpha; Laser Therapy; Lasers, Gas; Leg; Lymphatic Metastasis; Male; Melanoma; Palliative Care; Remission Induction; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2014 |
Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology.
Topics: Aminoquinolines; Antineoplastic Agents; Asymptomatic Diseases; Cryotherapy; Diagnostic Imaging; Evidence-Based Medicine; Follow-Up Studies; Humans; Hutchinson's Melanotic Freckle; Imiquimod; Lymphatic Metastasis; Melanoma; Nail Diseases; Neoplasm Grading; Neoplasm Staging; Sentinel Lymph Node Biopsy; Skin Neoplasms | 2011 |
Topical imiquimod eradicates skin metastases of malignant melanoma but fails to prevent rapid lymphogenous metastatic spread.
Topics: Administration, Topical; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Humans; Imiquimod; Lymphatic Metastasis; Male; Melanoma; Skin Neoplasms | 2002 |
Topical imiquimod in the treatment of metastatic melanoma to skin.
Topics: Adjuvants, Immunologic; Administration, Cutaneous; Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Combined Modality Therapy; Dacarbazine; Female; Humans; Imiquimod; Interferon alpha-2; Interferon-alpha; Knee; Leg; Lymphatic Metastasis; Male; Melanoma; Middle Aged; Neoplasm Recurrence, Local; Nitrosourea Compounds; Organophosphorus Compounds; Recombinant Proteins; Scalp; Skin Neoplasms; Treatment Outcome | 2003 |
Locoregional cutaneous metastases of malignant melanoma and their management.
Topics: Aged; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Female; Humans; Imiquimod; Lymphatic Metastasis; Male; Melanoma; Neoplasm Recurrence, Local; Neoplastic Cells, Circulating; Skin Neoplasms; Treatment Outcome | 2004 |
Minimizing surgery in skin cancer treatment. A new test looks for cancer in the lymph nodes during melanoma surgery, while a topical cream helps people with another form of skin cancer avoid the knife.
Topics: Adjuvants, Immunologic; Aminoquinolines; Antibodies, Neoplasm; Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Basal Cell; Humans; Imiquimod; Lymphatic Metastasis; Melanoma; Skin Neoplasms | 2005 |
Invasive squamous cell carcinoma after treatment of carcinoma in situ with 5% imiquimod cream.
Topics: Administration, Topical; Aged, 80 and over; Aminoquinolines; Antineoplastic Agents; Carcinoma in Situ; Carcinoma, Squamous Cell; Disease Progression; Head and Neck Neoplasms; Humans; Imiquimod; Leg; Lymph Node Excision; Lymphatic Metastasis; Male; Middle Aged; Neoplasms, Second Primary; Scalp; Skin Neoplasms; Treatment Outcome | 2006 |